Gilead Sciences — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Tentarixtentarix.cominSep 2023 · $35M
Tentarix Biotherapeutics develops multifunctional biologics to modernize healthcare standards through precision medicine.
BiotechDeep TechHealthtechMedical Devices
BoardSrini Akkaraju(Director, Founder)Paul Kang(Director, Founder)
Co-investorsVersant VenturesSamsara BioCapital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.